Research Article

Role of Annexin A1 in Squamous Cell Lung Cancer Progression

Table 1

Patient characteristics.

FeatureCasesSQCLCACSCLC

Total197818630
Age median (range)67 (37-84)67 (49-83)68 (34-84)67 (54-81)
Gender
 Male132 (67%)63 (47.7%)47 (35.6%)22 (16.7%)
 Female65 (33%)18 (27.7%)39 (60.0%)8 (12.3%)
Age
 ≥60144 (73%)59 (41%)63 (43.8%)22 (15.3%)
 <6053 (27%)22 (41.5%)23 (43.4%)8 (15.1%)
Lymph node metastasis
 Yes77 (41%)37 (48.1%)33 (42.9%)7 (9.1%)
 No112 (59%)44 (39.3%)52 (46.4%)16 (14.3%)
Degree of differentiation
 I+II125 (63%)64 (51.2%)61 (48.8%)0 (0.0%)
 III72 (37%)17 (23.6%)25 (34.7%)30 (41.7%)
Clinical stage
 I+II139 (74%)56 (40.3%)53 (45.3%)20 (14.4%)
 III+IV50 (26%)24 (48.0%)23 (46.0%)3 (6.0%)

Abbreviation: SQCLC: squamous cell lung cancer; AC: adenocarcinoma; SCLC: small cell.